Robert Phelps
Chief Executive Officer at Lophius Biosciences GmbH
Profile
Robert Phelps is currently the Chief Executive Officer & Managing Director at Lophius Biosciences GmbH since 2013.
Prior to this, he held various business development and licensing positions at PARI Pharma GmbH, Evotec SE, Bavarian Nordic A, Patheon UK Ltd., SuppreMol GmbH, and Hexal Gentech Forschungs GmbH.
He obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main in 1997.
Robert Phelps active positions
Companies | Position | Start |
---|---|---|
Lophius Biosciences GmbH
Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Chief Executive Officer | 2013-09-30 |
Former positions of Robert Phelps
Companies | Position | End |
---|---|---|
Hexal Gentech Forschungs GmbH
Hexal Gentech Forschungs GmbH BiotechnologyHealth Technology Hexal Gentech Forschungs GmbH develops biotechnology products. The company is located in Germany. | Corporate Officer/Principal | - |
EVOTEC SE | Corporate Officer/Principal | - |
Patheon UK Ltd.
Patheon UK Ltd. Pharmaceuticals: OtherHealth Technology Patheon UK Ltd. provides pharmaceutical drug development and manufacturing services. It provides its services to the pharmaceutical and biotechnology industries. The company is headquartered in Abingdon, UK | Corporate Officer/Principal | - |
BAVARIAN NORDIC A/S | Corporate Officer/Principal | - |
PARI Pharma GmbH
PARI Pharma GmbH Pharmaceuticals: MajorHealth Technology PARI Pharma GmbH Manufactures inhalant drugs. It offers aerosol inhalats and nebulizers which are primarily used against respiratory conditions. The company was founded in 1997 and is headquartered in Starnberg, Germany. | Corporate Officer/Principal | - |
Training of Robert Phelps
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
EVOTEC SE | Health Technology |
Private companies | 5 |
---|---|
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Health Technology |
PARI Pharma GmbH
PARI Pharma GmbH Pharmaceuticals: MajorHealth Technology PARI Pharma GmbH Manufactures inhalant drugs. It offers aerosol inhalats and nebulizers which are primarily used against respiratory conditions. The company was founded in 1997 and is headquartered in Starnberg, Germany. | Health Technology |
Patheon UK Ltd.
Patheon UK Ltd. Pharmaceuticals: OtherHealth Technology Patheon UK Ltd. provides pharmaceutical drug development and manufacturing services. It provides its services to the pharmaceutical and biotechnology industries. The company is headquartered in Abingdon, UK | Health Technology |
Hexal Gentech Forschungs GmbH
Hexal Gentech Forschungs GmbH BiotechnologyHealth Technology Hexal Gentech Forschungs GmbH develops biotechnology products. The company is located in Germany. | Health Technology |
Lophius Biosciences GmbH
Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Health Services |
- Stock Market
- Insiders
- Robert Phelps